These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8592420)

  • 21. Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function.
    Ikegami T; Nishizaki T; Hiroshige S; Ohta R; Yanaga K; Sugimachi K
    Br J Surg; 2001 Jan; 88(1):59-64. PubMed ID: 11136311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taurine improves graft survival after experimental liver transplantation.
    Schemmer P; Liang R; Kincius M; Flechtenmacher C; Bunzendahl H; Gutt CN; Mehrabi A; Gebhard MM; Büchler MW; Kraus TW
    Liver Transpl; 2005 Aug; 11(8):950-9. PubMed ID: 16035074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extent of vacuolation in non-heart-beating porcine donor liver grafts prior to transplantation predicts their viability.
    Monbaliu D; Libbrecht L; De Vos R; Vekemans K; Walter H; Liu Q; Heedfeld V; Goossens V; Pirenne J; Roskams T
    Liver Transpl; 2008 Sep; 14(9):1256-65. PubMed ID: 18756467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of thromboxane A2 (TXA2) in the early stages of oleic acid-induced lung injury and the preventive effect of ozagrel, a TXA2 synthase inhibitor, in guinea-pigs.
    Ishitsuka Y; Moriuchi H; Hatamoto K; Yang C; Takase J; Golbidi S; Irikura M; Irie T
    J Pharm Pharmacol; 2004 Apr; 56(4):513-20. PubMed ID: 15099446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of thromboxane B2 level in experimental orthotopic liver transplantation in swines--the effect of warm ischemia and thromboxane A2 synthetase inhibition.
    Urade M; Izumi R; Iyobe T; Iwasa K; Masutani H; Tani T; Yabushita K; Hashimoto T; Kiriyama M; Shimizu K
    Transplant Proc; 1992 Aug; 24(4):1623-4. PubMed ID: 1496677
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog.
    Iwata M
    Surg Today; 1994; 24(12):1056-67. PubMed ID: 7780227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Hashimoto S; Maehara Y; Kuwano H
    Transpl Int; 2005 Aug; 18(8):923-8. PubMed ID: 16008741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefit of Kupffer cell modulation with glycine versus Kupffer cell depletion after liver transplantation in the rat: effects on postischemic reperfusion injury, apoptotic cell death graft regeneration and survival.
    Rentsch M; Puellmann K; Sirek S; Iesalnieks I; Kienle K; Mueller T; Bolder U; Geissler E; Jauch KW; Beham A
    Transpl Int; 2005 Sep; 18(9):1079-89. PubMed ID: 16101730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostanoid release after lung transplantation.
    Kimblad PO; Gréen K; Sjöberg T; Steen S
    J Heart Lung Transplant; 1996 Oct; 15(10):999-1004. PubMed ID: 8913917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sildenafil extends survival and graft function in a large animal lung transplantation model.
    Korom S; Hillinger S; Cardell M; Zhai W; Tan Q; Dutly A; Leskosek B; Weder W
    Eur J Cardiothorac Surg; 2006 Mar; 29(3):288-93. PubMed ID: 16442298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
    Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
    Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Revitalizing donor livers after cardiovascular arrest with venous oxygen persufflation].
    Saad S; Minor T; Nagelschmidt M; Fu ZX; Kötting I; Paul A; Troidl H; Isselhard W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):705-8. PubMed ID: 14518345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothermic Liver Machine Perfusion With EKPS-1 Solution vs Aqix RS-I Solution: In Vivo Feasibility Study in a Pig Transplantation Model.
    Vekemans K; Liu Q; Heedfeld V; Van de Vel K; Wylin T; Pirenne J; Monbaliu D
    Transplant Proc; 2009 Mar; 41(2):617-21. PubMed ID: 19328939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-center experience with retrograde reperfusion in liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Stadlbauer V; Tscheliessnigg KH
    Transpl Int; 2003 Oct; 16(10):730-5. PubMed ID: 12819865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of a cyclooxygenase-2 inhibitor, FK3311, on total hepatic ischemia-reperfusion injury of the rat.
    Kobayashi M; Takeyoshi I; Kurabayashi M; Matsumoto K; Morishita Y
    Hepatogastroenterology; 2007 Mar; 54(74):522-6. PubMed ID: 17523312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia.
    Totsuka E; Dodson F; Urakami A; Moras N; Ishii T; Lee MC; Gutierrez J; Gerardo M; Molmenti E; Fung JJ
    Liver Transpl Surg; 1999 Sep; 5(5):421-8. PubMed ID: 10477844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Liver transplantation with no-heatbeating donor supplied gaseous oxygen during cold preservation in pigs].
    Fu Z; Saad S; Nagelschmidt M; Han W
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):17-9. PubMed ID: 11856492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphometric analysis of primary graft non-function in liver transplantation.
    Vertemati M; Sabatella G; Minola E; Gambacorta M; Goffredi M; Vizzotto L
    Histopathology; 2005 Apr; 46(4):451-9. PubMed ID: 15810957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fatty acid-binding protein: an early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors.
    Monbaliu D; de Vries B; Crabbé T; van Heurn E; Verwaest C; Roskams T; Fevery J; Pirenne J; Buurman WA
    Transplant Proc; 2005; 37(1):413-6. PubMed ID: 15808662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.